Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Inclusion Body Myositis: early-phase trial registry
3 of 11 indexed Inclusion Body Myositis trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #1,577 of 28,707 conditions by registered trial count.
11 US clinical trials · 3 currently recruiting · #1,577 of 28,707 conditions by registered trial count
Inclusion Body Myositis: 11 US clinical trials tracked, 3 recruiting.
Inclusion Body Myositis is the subject of 11 registered US clinical trials on ClinicalTrials.gov, 3 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most active sponsor is University of Kansas Medical Center, running 3 of these trials.
Enrollment posture brief
Registry condition inclusion-body-myositis
OPEN 3 | RECR 27% | LATE 1 | EARLY 2 | RANK #1577 | SPON 3
Volume-matched condition peers
Nearest open-share peer: Atherosclerotic Cardiovascular Disease (27% recruiting · 22 trials)
Inclusion Body Myositis lists 3 open slots (27% of 11 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Inclusion Body Myositis on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Inclusion Body Myositis is recruiting below its size-band peers.
3 of 11 indexed trials (27.3%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Inclusion Body Myositis research.
University of Kansas Medical Center accounts for 3 of 11 trials (27.3%). 9 distinct sponsors appear on at least one study for this condition label.
-
Most Inclusion Body Myositis trials plan to enrol fewer than 100 people.
Median target enrolment is 31 among the 11 trials that report a genuine target (sentinel values excluded). 7 of those (63.6%) plan for fewer than 100 participants.
-
Inclusion Body Myositis splits between interventional and observational designs.
5 interventional and 6 observational studies make up this index (45.5% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
11 total, page 1 of 1
Adult and Juvenile Myositis
National Institute of Environmental Health Sciences (NIEHS)
NCT00017914
MIHRA - Patient-Rooted Insights for Shaping Myositis Science (PRISMS)
Myositis International Health & Research Collaborative Alliance Foundation
NCT07374107
Effects of Whole-body Electrical Muscle Stimulation Exercise on Adults With Neuromuscular Disease
University of Missouri-Columbia
NCT07478172
Sporadic Inclusion Body Myositis Natural History Study
University of California, Irvine
NCT05046821
Phase III Trial of Sirolimus in IBM
University of Kansas Medical Center
NCT04789070
Monitoring Biomarker for Detecting Change in Physical Activity and Limb Function in Inclusion Body Myositis Over Time
University of Kansas Medical Center
NCT06153108
Establishing Muscle Impedance Parameters With Electrical Impedance Myography
Yale University
NCT03633318
Lithium in Inclusion Body Myositis (IBM)
Phoenix Neurological Associates
NCT00917956
Double-blind, Randomized, Placebo-controlled Trial of Etanercept for 12 Months in Subjects With Inclusion Body Myositis
Washington University School of Medicine
NCT00802815
Study of Pioglitazone in Sporadic Inclusion Body Myositis
Johns Hopkins University
NCT03440034
Inclusion Body Myositis Treatment With Celution Processed Adipose Derived Regenerative Cells
University of Kansas Medical Center
NCT04975841
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 2 |
| Phase 3 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Inclusion Body Myositis records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Inclusion Body Myositis trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Inclusion Body Myositis page
11 registered trials, 3 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 3 Inclusion Body Myositis trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- University of Kansas Medical Center sponsors the most Inclusion Body Myositis trials on record, review their full trial history before evaluating a specific study. See University of Kansas Medical Center's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Inclusion Body Myositis condition card totals 11 registered trials; most-linked intervention electrical impedance myography (EIM); top US site state Maryland. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.